Ledger.Open graph →

SEC Form D · filed July 31, 2019

Solid Biosciences Inc

Offering

$60.0M

Sold

$60.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Cambridge, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Lisa Audet · Greenwich, CTExec Jared Kehe · Allston, MAExec Jeffrey B. Beir · Boston, MAExec Samuel B. Cates · Boston, MAExec · Director Lorenzo Delzoppo · WILMINGTON, DEDirector Pavel Livshiz · New York, NYDirector Mark Goode · WILMINGTON, DEDirector Adam Mullinax · Boston, MAExec Martin A. Freed · Cambridge, MADirector Rajeev A. Shah · Cambridge, MADirector Ron Efroni Rotman · New York, NYDirector Luke Walker · WILMINGTON, DEDirector David Shainok · New York, NYDirector Chris M. Rosenthal · BALTIMORE, MDDirector Wayne M. Rehberger · BALTIMORE, MDDirector Keith M. Jackson · BALTIMORE, MDDirector Tom Werthan · BALTIMORE, MDDirector Andrew Gavin · BALTIMORE, MDDirector Charles Boatin · Saint-Pierre, O4Director Florent De Boissieu · Saint-Pierre, O4Director Stephane Bacquaert · Saint-Pierre, O4Director Martha Osier · Saint-Pierre, O4Exec Nnennia Ejebe · Saint-Pierre, O4Exec Alexis Caude · Saint-Pierre, O4Exec Christophe Scalbert · Saint-Pierre, O4Exec · Director Antoine Delaporte · Saint-Pierre, O4Exec Alvaro Amorrortu · Cambridge, MAExec Andrey A. Zarur · Cambridge, MADirector Jorge A. Quiroz · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗